Lavipharm S.A.
LAVI
Rank in Stocks
#15056
Lavipharm S.A. is a company that specializes in the comprehensive lifecycle of... Lavipharm S.A. is a company that specializes in the comprehensive lifecycle of pharmaceutical, dermocosmetic, and general healthcare products, from initial research and development to manufacturing, importation, marketing, and distribution. Its operations span both the Greek domestic market and international territories. The company's diverse pharmaceutical offerings cater to numerous therapeutic areas, including cardiology, chronic pain management, oncology, central nervous system disorders, general medicine, gastrointestinal health, and urology. In addition to prescription medications, Lavipharm provides a range of over-the-counter (OTC) drugs such as antiseptics, analgesics, and anti-lice treatments, alongside various skincare solutions. This enterprise, headquartered in Paiania, Greece, was established in 1911.
Share Price
$1.67
Last synced: 2026-11-09
Market Cap
$285.19M
Change (1 day)
3.31%
Change (1 year)
75.57%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Lavipharm S.A. (LAVI)
Category
Healthcare
EPS for Lavipharm S.A. (LAVI)
EPS as of June 2026 TTM: $0.04
According to Lavipharm S.A.'s latest financial reports, its current EPS (TTM) is $0.04. At the end of 2025 the company had an EPS of $0.04, a decrease compared to its 2024 EPS of $0.06.
EPS history for Lavipharm S.A. from 2016 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.04 | -5.25% |
| 2025 | $0.04 | -25.36% |
| 2024 | $0.06 | 352.03% |
| 2023 | $0.01 | -70.36% |
| 2022 | $0.04 | -61.25% |
| 2021 | $0.11 | -20.07% |
| 2020 | $0.13 | -58.82% |
| 2019 | $0.33 | 314.52% |
| 2018 | $0.08 | -90.79% |
| 2017 | $0.85 | 304.90% |
| 2016 | $0.21 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | 17,054.09% |
DE
|
|
| $6.08 | 15,935.88% |
DE
|
|
| $1.55 | 3,991.29% |
JP
|
|
| $3.66 | 9,556.99% |
CH
|
|
| $0.45 | 1,087.34% |
IL
|
Questions about Lavipharm S.A.'s earnings per share (EPS)
What is Lavipharm S.A.'s earnings per share (EPS)?
Lavipharm S.A.'s earnings per share (EPS) over the last twelve months is $0.04, as of Jun 2026.
What was Lavipharm S.A.'s earnings per share (EPS) in 2025?
In 2025, Lavipharm S.A.'s earnings per share (EPS) was $0.04, 33.33% less than in 2024 ($0.06).
How has Lavipharm S.A.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Lavipharm S.A.'s earnings per share (EPS) went from $0.13 to $0.04, an average decline of 21.00% a year.
How does Lavipharm S.A.'s earnings per share (EPS) compare with similar companies?
Lavipharm S.A.'s earnings per share (EPS) ($0.04) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.